Skip to main content
. 2019 Dec 19;19:1714. doi: 10.1186/s12889-019-8062-9

Table 2.

Data characteristics by survey year and HIV status (%)

1988 2001 2012
HIV+ HIV HIV+ HIV HIV+ HIV
Age distribution 0–15 years 8 23 0 0 0 0
16–24 years 26 21 6 6 6 6
25–34 years 38 25 39 33 0 0
35–44 years 11 21 39 39 44 33
45–54 years 17 11 17 22 22 33
55–88 years 0 0 0 0 28 28
N (53) (53) [18] [18] [18] [18]
Factor use (per year) 0–25.000 units 8 12 0 0 6 6
25.001–75.000 units 10 20 20 19 28 22
75.001–125.000 units 22 16 35 38 11 22
125.001–250.000 units 46 37 35 33 17 22
250.001–500.000 units 8 12 10 5 33 22
500.001- units 6 2 0 5 6 6
N (49) (50) [21] [20] [18] [18]
Hepatitis B or C Never 46a 63a 5 5 6 6
Current or previous 54a 37a 95 95 94 94
N (46) (46) [21] [21] [18] [18]
Bleeding episodes No episodes 6 4 5 0 6 6
1–10 episodes 34 53 53 50 61 33
11–25 episodes 30 8 26 15 17 39
26–50 episodes 19 21 16 25 11 11
51+ episodes 11 15 0 10 6 11
N (53) (53) [20] [19] [18] [18]
Severity of hemophilia Severe 100 100 89 100
Moderate 0 0 11 0
N [21] [21] [18] [18]
Inhibitor (ever) Never 77 84 81 90 67 67
Current or previous 23 16 19 10 33 33
N (50) (52) [21] [21] [18] [18]
Joint mobility 0 13 9 24 14 17 22
1 17 17 10 5 6 22
2 25 9 19 24 44 17
3 15 21 10 24 17 22
4 17 13 38 24 11 11
5 12 30 0 10 6 6
N

aOnly HBV